{
    "Trade/Device Name(s)": [
        "ADVIA\u00ae Chemistry Microalbumin Controls",
        "ADVIA\u00ae Chemistry Microalbumin Control"
    ],
    "Submitter Information": "Bayer HealthCare LLC",
    "510(k) Number": "K052242",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043266"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "October 3, 2005",
    "Summary Letter Received Date": "August 18, 2005",
    "Submission Date": "August 12, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Microalbumin"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA\u00ae Chemistry systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA\u00ae Chemistry Microalbumin Controls as quality control material for the ADVIA\u00ae Chemistry systems microalbumin method",
    "Indications for Use Summary": "Intended for in vitro diagnostic use in the control of ADVIA\u00ae Chemistry systems for the Microalbumin method",
    "fda_folder": "Clinical Chemistry"
}